Skip to main content


The regulatory framework for therapeutic goods is made up of Acts of Parliament and a series of other subordinate legislative instruments.

The Therapeutic Goods Act 1989, regulations and orders set out the requirements for inclusion of therapeutic goods in the Australian Register of Therapeutic Goods, including advertising, labelling, product appearance and appeal guidelines. Some provisions, such as the scheduling of substances and the safe storage of therapeutic goods, are covered by the relevant state or territory legislation.

Australian legislation in full text is available from the Attorney General's Federal Register of Legislation - external site.

If you intend to rely on any legislation referred to on this website, you should access copies of the official versions. Our instruments are amended from time to time and may occasionally be replaced or new instruments made.


Latest alerts

  • EVE Allylisopropylacetylurea tablets

    The TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
  • Counterfeit semaglutide vials

    The TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.

Latest articles

  • Update to listed medicine ingredients in June 2024

    Find out how listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024, which commenced on 14 June 2024.
  • Stage 2 of vaping reforms introduced in Parliament

    The Minister for Health and Aged Care, the Hon Mark Butler MP, introduced a bill that aims to reduce the widespread availability of vapes by controlling all levels of the supply chain.

Latest publications

Help us improve the Therapeutic Goods Administration site